Zobrazeno 1 - 10
of 1 211
pro vyhledávání: '"L. Winters"'
Autor:
Jonathon W. Senefeld, PhD, Ellen K. Gorman, BS, Patrick W. Johnson, BS, M. Erin Moir, PhD, Stephen A. Klassen, PhD, Rickey E. Carter, PhD, Nigel S. Paneth, MD, David J. Sullivan, MD, Olaf H. Morkeberg, BA, R. Scott Wright, MD, DeLisa Fairweather, PhD, Katelyn A. Bruno, PhD, Shmuel Shoham, MD, Evan M. Bloch, MBChB, MS, Daniele Focosi, MD, Jeffrey P. Henderson, MD, PhD, Justin E. Juskewitch, MD, PhD, Liise-Anne Pirofski, MD, Brenda J. Grossman, MD, MPH, Aaron A.R. Tobian, MD, PhD, Massimo Franchini, MD, Ravindra Ganesh, MBBS, MD, Ryan T. Hurt, MD, PhD, Neil E. Kay, MD, Sameer A. Parikh, MBBS, Sarah E. Baker, PhD, Zachary A. Buchholtz, BS, Matthew R. Buras, BS, Andrew J. Clayburn, BS, Joshua J. Dennis, BS, Juan C. Diaz Soto, MD, Vitaly Herasevich, MD, PhD, Allan M. Klompas, MB, BCh, BAO, Katie L. Kunze, PhD, Kathryn F. Larson, MD, John R. Mills, PhD, Riley J. Regimbal, BS, Juan G. Ripoll, MD, Matthew A. Sexton, MD, John R.A. Shepherd, MD, James R. Stubbs, MD, Elitza S. Theel, PhD, Camille M. van Buskirk, MD, Noud van Helmond, MD, Matthew N.P. Vogt, MD, Emily R. Whelan, BS, Chad C. Wiggins, PhD, Jeffrey L. Winters, MD, Arturo Casadevall, MD, PhD, Michael J. Joyner, MD
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 7, Iss 5, Pp 499-513 (2023)
Objective: To examine the association of COVID-19 convalescent plasma transfusion with mortality and the differences between subgroups in hospitalized patients with COVID-19. Patients and Methods: On October 26, 2022, a systematic search was performe
Externí odkaz:
https://doaj.org/article/dadeeaf646b74fc8991c25a417a35f18
Autor:
Allan M. Klompas, Noud van Helmond, Justin E. Juskewitch, Rajiv K. Pruthi, Matthew A. Sexton, Juan C. Diaz Soto, Stephen A. Klassen, Katherine A. Senese, Camille M. van Buskirk, Jeffrey L. Winters, James R. Stubbs, Scott A. Hammel, Michael J. Joyner, Jonathon W. Senefeld
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-7 (2022)
Abstract Convalescent plasma is used to treat COVID-19. There are theoretical concerns about the impact of pro-coagulant factors in convalescent plasma on the coagulation cascade particularly among patients with severe COVID-19. The aim of this study
Externí odkaz:
https://doaj.org/article/1ea37d3027384172afef5fe3b22db1ea
Autor:
Katie L. Kunze, Patrick W. Johnson, Noud van Helmond, Jonathon W. Senefeld, Molly M. Petersen, Stephen A. Klassen, Chad C. Wiggins, Allan M. Klompas, Katelyn A. Bruno, John R. Mills, Elitza S. Theel, Matthew R. Buras, Michael A. Golafshar, Matthew A. Sexton, Juan C. Diaz Soto, Sarah E. Baker, John R. A. Shepherd, Nicole C. Verdun, Peter Marks, Nigel S. Paneth, DeLisa Fairweather, R. Scott Wright, Camille M. van Buskirk, Jeffrey L. Winters, James R. Stubbs, Katherine A. Senese, Michaela C. Pletsch, Zachary A. Buchholtz, Robert F. Rea, Vitaly Herasevich, Emily R. Whelan, Andrew J. Clayburn, Kathryn F. Larson, Juan G. Ripoll, Kylie J. Andersen, Elizabeth R. Lesser, Matthew N. P. Vogt, Joshua J. Dennis, Riley J. Regimbal, Philippe R. Bauer, Janis E. Blair, Arturo Casadevall, Rickey E. Carter, Michael J. Joyner
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-6 (2021)
Regional differences in SARS-CoV-2 variants may affect treatment outcome. Here, the authors show that near-sourced convalescent plasma has higher efficacy, as defined by death within 30 days of transfusion, than plasma sourced more than 150 miles awa
Externí odkaz:
https://doaj.org/article/b4c2e18825314c909846a2c6aed3901d
Autor:
Svetomir Markovic, Haidong Dong, Nathan Foster, Jacob J Orme, Sean S Park, Jeffrey L Winters, Tara M Davidson, Fabrice Lucien
Publikováno v:
BMJ Open, Vol 12, Iss 5 (2022)
Background Patients with metastatic melanoma rely on PD-(L)1 immunotherapy, but only one-third of patients experience treatment response and all initial responders eventually develop resistance. Tumour-derived extracellular vesicles expressing Progra
Externí odkaz:
https://doaj.org/article/0b6f47902c314b00ac2a6c0aafe30a5c
Autor:
Jonathon W Senefeld, Patrick W Johnson, Katie L Kunze, Evan M Bloch, Noud van Helmond, Michael A Golafshar, Stephen A Klassen, Allan M Klompas, Matthew A Sexton, Juan C Diaz Soto, Brenda J Grossman, Aaron A R Tobian, Ruchika Goel, Chad C Wiggins, Katelyn A Bruno, Camille M van Buskirk, James R Stubbs, Jeffrey L Winters, Arturo Casadevall, Nigel S Paneth, Beth H Shaz, Molly M Petersen, Bruce S Sachais, Matthew R Buras, Mikolaj A Wieczorek, Benjamin Russoniello, Larry J Dumont, Sarah E Baker, Ralph R Vassallo, John R A Shepherd, Pampee P Young, Nicole C Verdun, Peter Marks, N Rebecca Haley, Robert F Rea, Louis Katz, Vitaly Herasevich, Dan A Waxman, Emily R Whelan, Aviv Bergman, Andrew J Clayburn, Mary Kathryn Grabowski, Kathryn F Larson, Juan G Ripoll, Kylie J Andersen, Matthew N P Vogt, Joshua J Dennis, Riley J Regimbal, Philippe R Bauer, Janis E Blair, Zachary A Buchholtz, Michaela C Pletsch, Katherine Wright, Joel T Greenshields, Michael J Joyner, R Scott Wright, Rickey E Carter, DeLisa Fairweather
Publikováno v:
PLoS Medicine, Vol 18, Iss 12, p e1003872 (2021)
BackgroundThe United States (US) Expanded Access Program (EAP) to coronavirus disease 2019 (COVID-19) convalescent plasma was initiated in response to the rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative age
Externí odkaz:
https://doaj.org/article/b6326af583c74bfba59628eb0bc601dc
Autor:
Robin Patel MD, Nicole Lynn Hoppman PhD, Cindy M. Gosse MS, Deborah J. Hagen-Moe MEd, Susan K. Dunemann MBA, Justin D. Kreuter MD, Sharon A. Preuss MBA, Jeffrey L. Winters MD, Charles D. Sturgis MD, Joseph J. Maleszewski MD, Malvika H. Solanki MBBS, Bobbi S. Pritt MD, Michael Rivera MD, Ann M. Mairose BS, Michelle A. Nelsen MS, Kara L. Hansing MS, Susan M. Lehman MA, MLS, Randy C. Gruhlke MS, Jennifer M. Boland MD
Publikováno v:
Academic Pathology, Vol 8 (2021)
The rapidly spreading COVID-19 pandemic demanded immediate organizational pivots in departments of laboratory medicine and pathology, including development and implementation of severe acute respiratory syndrome coronavirus 2 diagnostics in the face
Externí odkaz:
https://doaj.org/article/b05c87f9a3344d21a5e6ea18581a3bd8
Autor:
Sherelle L. Casey, Vanessa A. Mitchell, Eddy E. Sokolaj, Bryony L. Winters, Christopher W. Vaughan
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 15, p 8649 (2022)
(1) Background: The psychoactive and non-psychoactive constituents of cannabis, Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD), synergistically reduce allodynia in various animal models of neuropathic pain. Unfortunately, THC-containing drugs a
Externí odkaz:
https://doaj.org/article/e3d534e5f8344225a1209868f6098472
Autor:
Aldo A. Acosta-Medina, Ann M. Moyer, Ronald S. Go, Maria Alice V. Willrich, Fernando C. Fervenza, Nelson Leung, Christianne Bourlon, Jeffrey L. Winters, Grant M. Spears, Sandra C. Bryant, Meera Sridharan
Publikováno v:
Blood Advances. 7:340-350
Eculizumab is effective for complement-mediated thrombotic microangiopathy (CM-TMA), also known as atypical hemolytic uremic syndrome. Although lifelong therapy had been suggested, discontinuation does not universally lead to relapse. Comprehensive d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8964a6a229eefdca4bf349000553f02
https://doi.org/10.1182/bloodadvances.2021006416
https://doi.org/10.1182/bloodadvances.2021006416
Autor:
Haidong Dong, Svetomir N Markovic, Aaron S Mansfield, Jacob J Orme, Elizabeth Ann L Enninga, Fabrice Lucien-Matteoni, Heather Dale, Edwin Burgstaler, Susan M Harrington, Matthew K Ball, Sean S Park, Mathew S Block, Yiyi Yan, Roxana S Dronca, Jeffrey L Winters
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Background Trans-acting programmed death-ligand 1 (PD-L1) derives from malignant cells in three known forms. High levels of secreted splice variant PD-L1 (sPD-L1), ADAM10/ADAM17-shed sPD-L1, and PD-L1-positive extracellular vesicles (evPD-L1) each pr
Externí odkaz:
https://doaj.org/article/12cda94bbdc0496a8a76193abb6aa4f3
Autor:
Thomas T DeLeon, Daniel R Almquist, Benjamin R Kipp, Blake T Langlais, Aaron Mangold, Jennifer L Winters, Heidi E Kosiorek, Richard W Joseph, Roxana S Dronca, Matthew S Block, Robert R McWilliams, Lisa A Kottschade, Kandelaria M Rumilla, Jesse S Voss, Mahesh Seetharam, Aleksandar Sekulic, Svetomir N Markovic, Alan H Bryce
Publikováno v:
PLoS ONE, Vol 15, Iss 3, p e0230306 (2020)
BACKGROUND:CDKN2A and TP53 mutations are recurrent events in melanoma, occurring in 13.3% and 15.1% of cases respectively and are associated with poorer outcomes. It is unclear what effect CDKN2A and TP53 mutations have on the clinical outcomes of pa
Externí odkaz:
https://doaj.org/article/3927fd1a2b3d44719753600a2b2972b4